Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Pool Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108409639B details a novel chiral synthesis route eliminating resolution agents. Achieve significant cost reduction and supply reliability for cardiovascular intermediates.
Patent CN107540574B reveals a cost-effective D-tyrosine route for R-biphenylalaninol, offering high purity and scalable production for Entresto intermediates.
Advanced preparation method for optically pure 2-methyl alkyl glycol derivatives from lactones. Enables scalable production of chiral synthetic building blocks for pharmaceutical and agrochemical intermediates.
Patent CN101239938A details a cost-effective L-Malic acid route for S-4-hydroxypyrrolidone, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel diazotization route avoids toxic cyanide. Scalable cosmetic intermediate manufacturing with high purity and reduced environmental impact.
Novel chiral synthesis via diketopiperazine avoids toxic cyanide. High yield, scalable process for selenium supplements and pharmaceutical intermediates.
Patent CN102464589A details a high-yield route for Rasagiline mesylate using chiral aminolysis and alkylation, offering significant cost reduction in API manufacturing.
Patent CN101585778A details a scalable route from S-(+)-leucine avoiding toxic azides. Ideal for reliable lyrica intermediate supplier sourcing and cost reduction.
Patent CN1054980A details chiral synthesis of 3-amino-4-methylpyrrolidine derivatives from natural amino acids, enabling high-purity quinolone antibiotic production with improved supply chain stability.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1189458C details a chiral pool synthesis of key Substance P antagonists. Discover cost-effective manufacturing and supply chain advantages.
Novel synthetic method for penem antibiotic intermediate 4AA using L-threonine. High purity 99.34%, scalable process, cost-effective manufacturing solution.
Patent CN1978442A details a novel mannitol-based route for Nepyrrolol HCl, offering improved purity and scalability for reliable pharmaceutical intermediate suppliers.
Patent CN101696185A details a high-yield synthesis of 6-nitro-S-(-)-indoline-2-carboxylic acid from L-phenylalanine, offering cost-effective chiral intermediate solutions.
Patent CN101696185A details a high-yield chiral synthesis route. We offer reliable supply and cost reduction in pharmaceutical intermediates manufacturing.
Novel eight-step synthesis from L-asparagine avoids chiral resolution, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Advanced synthesis of Saquinavir intermediate via L-Phenylalanine. High yield (75%), >99% optical purity. Cost-effective route for API manufacturing.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.
Advanced chiral synthesis of pregabalin via dibenzylamine intermediates. Reduces genotoxic risks and improves scalability for reliable API manufacturing supply chains.
Novel Entecavir preparation method enhances yield and purity. Reduces manufacturing complexity for reliable pharmaceutical intermediate supply chain stability.